𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mechanical implications of estrogen supplementation in early postmenopausal women

✍ Scribed by Felix W Wehrli; Chamith S Rajapakse; Jeremy F Magland; Peter J Snyder


Publisher
American Society for Bone and Mineral Research
Year
2010
Tongue
English
Weight
207 KB
Volume
25
Category
Article
ISSN
0884-0431

No coin nor oath required. For personal study only.

✦ Synopsis


Whereas the structural implications of drug intervention are well established, there are few data on the possible mechanical consequences of treatment. In this work we examined the changes in elastic and shear moduli (EM and SM) in a region of trabecular bone in the distal radius and distal tibia of early postmenopausal women on the basis of MRI-based micro-finite-element (Β΅FE) analysis. Whole-section axial stiffness (AS) encompassing both trabecular and cortical compartments was evaluated as well. The study was conducted on previously acquired high-resolution images at the two anatomic sites. Images were processed to yield a 3D voxel array of bone-volume fraction (BVF), which was converted to a Β΅FE model of hexahedral elements in which tissue modulus was set proportional to voxel BVF. The study comprised 65 early postmenopausal women (age range 45 to 55 years), of whom 32 had chosen estrogen supplementation (estradiol group); the remainder had not (control group). Subjects had been scanned at baseline and 12 and 24 months thereafter. At the distal tibia, EM and SM were reduced by 2.9% to 5.5% in the control group (p < .05 to <.005), but there was no change in the estradiol subjects. AS decreased 3.9% (4.0%) in controls (p < .005) and increased by 5.8% (6.2%) in estradiol group subjects (p < .05) at 12 (24) months. At the distal radius, EM and SM changes from baseline were not significant, but at both time points AS was increased in estradiol group subjects and decreased in controls (p < .005 to <.05), albeit by a smaller margin than at the tibia. EM and SM were strongly correlated with BV/TV (r^2^ = 0.44 to 0.92) as well as with topologic parameters expressing the ratio of plates to rods (r^2^ = 0.45 to 0.82), jointly explaining up to 96% of the variation in the mechanical parameters. Finally, baseline AS was strongly correlated between the two anatomic sites (r^2^ = 0.58), suggesting that intersubject variations in the bone's mechanical competence follows similar mechanisms. In conclusion, the results demonstrate that micro-MRI-based Β΅FE models are suited for the study of the mechanical implications of antiresorptive treatment. The data further highlight the anabolic effect of short-term estrogen supplementation. Β© 2010 American Society for Bone and Mineral Research.


πŸ“œ SIMILAR VOLUMES


Risk of early recurrence among postmenop
✍ Hagen Kennecke; Heather McArthur; Ivo A. Olivotto; Caroline Speers; Chris Bajdik πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 162 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Adjuvant aromatase inhibitors (AIs), instead of or after tamoxifen, are effective in decreasing recurrence in postmenopausal women with estrogen receptor (ER)‐positive breast cancer. An understanding of which patients are at risk of early recurrence while they are receivi

Clinical development of estrogen modulat
✍ Julia A. Lawrence; Phyllis B. Malpas; Caroline C. Sigman; Gary J. Kelloff πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 103 KB πŸ‘ 2 views

Tamoxifen has proven to be beneficial in the chemoprevention of breast cancer in women at increased risk for the disease. Other compounds that mediate the estrogen pathway remain to be tested for clinical efficacy. The mechanism of action, efficacy, and dose response of the estrogen modulators is de

Smoking is associated with postmenopausa
✍ Jonas Manjer; Robert Johansson; Per Lenner πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 French βš– 72 KB πŸ‘ 2 views

## Abstract We investigated the association between smoking and risk of postmenopausal breast cancer in groups defined by high levels of estrogens, a factor known to enhance tumour progression. Two prospective cohorts of Swedish women provided 260 postmenopausal breast cancer cases and 514 controls

Summary of aromatase inhibitor clinical
✍ Aman U. Buzdar; R. Charles Coombes; Paul E. Goss; Eric P. Winer πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 115 KB

Five years of adjuvant therapy with tamoxifen was considered the gold-standard treatment for postmenopausal women with estrogen receptor-positive breast cancer for many years. Data from a core group of clinical trials investigating the safety and efficacy of aromatase inhibitors (AIs) have challenge

The expression of estrogen receptors in
✍ Jae Kwang Kim; Hoo Jae Hann; Mi Jin Kim; Jeong Suh Kim πŸ“‚ Article πŸ“… 2010 πŸ› Elsevier Science 🌐 English βš– 399 KB

## Abstract The purpose of this study was to investigate estrogen receptor (ER) expression in tenosynovial tissues of postmenopausal woman with idiopathic carpal tunnel syndrome (CTS) to determine whether estrogen contributes to the pathogenesis of this condition. Biopsy samples of tenosynovial tis